Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06574789 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

Study acronym: ID-MAGIC
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 1 of 7 sitesv8
  2. Site details revised at 2 of 7 sitesv7
  3. Site details revised at 1 of 7 sitesv6
  4. Site details revised at 1 of 7 sitesv5
  5. Site details revised at 1 of 7 sitesv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 2024 to Oct 29, 2024 · Site details revised at 7 of 7 sitesv3 Show 2 more changesShow less
    • Start date changed from estimate of Sep 2024 to Oct 29, 2024
    • Site details revised at 7 of 7 sites
  2. Start date: Aug 2024 to Sep 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being conducted at seven major children's hospitals in Australia and New Zealand to test a new approach for treating a virus, called cytomegalovirus in children with weakened immune systems. The researchers want to find out if using a web app to customise the dose of a medication called ganciclovir is better at clearing the virus over a six-week period compared to the standard method of giving the medication.
Trial Details
NCT Number NCT06574789
Lead Sponsor Murdoch Childrens Research Institute
Conditions Cytomegalovirus Viraemia
Enrollment 232 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov